Eight out of 10 countries using mHealth services, WHO report says

Eighty-three percent of countries are using mobile phone technology for health services, according to a WHO study (.pdf) released on Tuesday at the Mobile Health Summit in Cape Town, South Africa, Agence France-Presse reports (6/7).

"The four-day Cape Town summit brings together principally mobile operators, handset manufacturers, providers of tele-medicine equipment, health insurance companies, the pharmaceutical industry and government representatives," according to the Guardian (Smith, 6/8).

The WHO study found that out of 114 countries, only 19 had no mobile health initiative, AFP writes. "Globally, the most common schemes for cell phones were call centres or help-lines, emergency toll-free numbers, and mobile telemedicine - such as doctors consulting one another. Among the biggest barriers worldwide were cost, a lack of knowledge and health policies that did not recognise mHealth, the study found," according to the news agency (6/7).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aptamer extends agreement with genetic medicines customer